HER2 LOW BREAST CARCINOMA
Clinical trials for HER2 LOW BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HER2 LOW BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for HER2 LOW BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New targeted drug trial offers hope for Tough-to-Treat breast cancer
Disease control Not yet recruitingThis study is testing whether a new drug called ARX788 can help control advanced breast cancer that has a specific low level of a protein called HER2. The drug is given by IV infusion and works by attaching a cancer-killing toxin directly to tumor cells. Researchers will enroll 3…
Matched conditions: HER2 LOW BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Laura Huppert, MD, BA • Aim: Disease control
Last updated Apr 03, 2026 21:41 UTC
-
New hope for Tough-to-Treat breast cancer: testing a powerful drug duo
Disease control Not yet recruitingThis study is testing whether combining two drugs, elacestrant and trastuzumab deruxtecan, can help control advanced breast cancer that has grown despite prior hormone-based therapies. It will involve about 65 people with specific types of breast cancer (HR+/HER2-low or ultralow)…
Matched conditions: HER2 LOW BREAST CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Sarah Sammons, MD • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC